MedTrace Logo

The ENHANCE Project Toolkit

NCT07649278 · Status: RECRUITING · Phase: NA · Type: INTERVENTIONAL · Enrollment: 40

Last updated 2026-07-14

No results posted yet for this study

Summary

This study will examine the feasibility, appropriateness, and acceptability of a bundle of smartphone-based tools for lowering overdose risk. 40 participants will be enrolled and can expect to be on study for up to 9 months.

Conditions

  • Substance Related Disorder
  • Drug Overdose
  • eHealth

Interventions

DEVICE

Connections mHealth Application

Mobile health app, bundled with other harm reduction internet and phone resources

Sponsors & Collaborators

  • National Institute on Drug Abuse (NIDA)

    collaborator NIH

  • University of Wisconsin, Madison

    lead OTHER

Principal Investigators

  • Rachel Gicquelais, PhD, MPH · UW School of Medicine and Public Health

  • Ryan Westergaard, MD, PhD, MPH · UW School of Medicine and Public Health

Study Design

Allocation
NA
Purpose
DEVICE_FEASIBILITY
Masking
NONE
Model
SINGLE_GROUP

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2026-07-01
Primary Completion
2027-06-30
Completion
2027-06-30
FDA Device
Yes

Countries

  • United States

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT07649278 on ClinicalTrials.gov